跳至主要内容
临床试验/CTRI/2024/01/062060
CTRI/2024/01/062060尚未招募4 期

A Randomized clinical study to evaluate the efficacy of sirvyadha with or without jatamayadi lepa in vata - rakta w.s.r to gout - NI

Dr Sambu Surendran0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • a.Subject with hyperuricemia and presenting with lakshanas of Vatarakta.
  • b.Chronicity less than 5 years,
  • c.Not associated with complete joint destruction.
  • d.Uric acid above 7 mg/dl

排除标准

  • a.Subject with major illness like hepatitis, AIDS, malignancy and RA factor positive.
  • b.Subject with uncontrolled diabetes mellitus and hypertension, Koch’s arthritis, Septic arthritis, Chronic renal failure, Severe Systemic multi organ syndromes and uric acid cristal stones.
  • c.Subjects on opioids, anticoagulant drugs.
  • d.Classical contraindications for siravyadha procedure.

研究者

发起方
Dr Sambu Surendran

相似试验